Professor Sheila Francis
BSc PhD SFHEA FRSB
School of Medicine and Population Health
Faculty Director of One University Strategy Delivery (FDOU)
Professor of Cardiovascular Biology
+44 114 215 9501
Full contact details
School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX
- Profile
-
For enquiries, please contact – SMPH-West-Operational@sheffield.ac.uk
For One University Strategy enquiries in the Faculty of Health, please contact Isabel Andrews.
I joined the University of Sheffield in 1990 after a BBSRC CASE PhD studentship at the University of Manchester. After four years as a Postdoctoral Research Associate in Cardiac Surgery (with Angelini) and Molecular Medicine (with Duff), I held an Independent Open Competition Fellowship from the Lloyd´s Tercentenary Foundation on the molecular and inflammatory basis of coronary artery disease.
After being appointed Lecturer in 1994, I spent a sabbatical period in the at MIT as a Fulbright Scholar. I am currently a Professor of Cardiovascular Biology at the University of Sheffield.
HAGE (Heart Attack Gene Expression) Shiny application
Quickly visualise and analyse the expression of your genes of interest in whole blood of MI patients.
Compare gene expression between different MI types, patient characteristics, and different days following acute MI.
Current PhD opportunities:
- Research interests
-
I have a long-standing interest in the role of interleukin-1 (IL-1) and its naturally occurring antagonist, IL-1ra in modulating vascular cell function in experimental models and in human disease. Over the past 10-15 years, I have shown that IL-1 and IL-1ra are increased in diseased human arteries and in other experimental cardiovascular systems. I described the association of a genetic variant of IL-1ra with coronary artery disease and showed that this variant alters protein levels and the biology of endothelial cells.
Programme funding from the British Heart Foundation (with Professor David Crossman) allowed the use of strategies to inhibit IL-1 in several experimental models including atherosclerosis in mice. The impact of this early work alongside that of others has now been translated to man through the ILA-HEART and .
My current research areas of interest relate to the mechanisms by which IL-1 is released from vascular cells especially endothelial cells, IL-1 related molecules and their antagonists, and the role of IL-1 in complex vascular phenotypes such as inflammatory vascular plaques in the brain and the mixed models of atherosclerosis after chronic infection and also episodes of hypoglycaemia. More recently, I have become interested in the control of endothelial senescence and impacts upon age-related diseases working with colleague in HELSI.
I collaborate with colleagues in Infection, Immunity and Cardiovascular Disease, Metabolism, Psychology and Neuroscience at the University of Sheffield and with colleagues at the Universities of Manchester (Pinteaux, Allan), the University of Virginia (Owens, Abbate) and others.
Current projects
- Release of IL-1 from vascular cells especially endothelial cells.
- S.pneumoniae infection and atherosclerosis (with Bazaz and Dockrell (Edinburgh)).
- Hypoglycaemia and risk of atherosclerosis (with Iqbal and Heller).
- Interleukin-1 alpha versus interleukin-1 beta in atherosclerosis, hypertension and stroke (with Pinteaux and Allan, Manchester)).
- Macrophage phenotypes in human carotid atherosclerosis (with Kiss-Toth and Redgrave).
- Neurovascular function in atherosclerosis (with Wharton, Berwick and Howarth).
- Approaches to alter endothelial senescence and ageing (with Bellantuono).
- PKC alpha/TGF beta axis in atherosclerosis and medical calcification (with Brennan, Canfield and Borland, Manchester)
- Vascular Brain pathology (with Simpson and Wharton)
- Inflammation, atherosclerosis and molecular manipulation of the microbiome (with Jon Shaw)
- Publications
-
Show: Featured publications All publications
Featured publications
Journal articles
- . Neurophotonics, 12(S1).
- . Atherosclerosis, 404.
- . Neurophotonics, 12(S1).
- . Cardiovascular Research, 121(5), 748-759.
- . Journal of the American Heart Association, 13(5).
- . Frontiers in Cellular and Infection Microbiology, 13.
- . Alzheimer's & Dementia, 18(S6).
- . Vascular Biology, 4(1), 11-18.
- . Science Advances, 8(35).
- . Frontiers in Cardiovascular Medicine, 9.
- . eLife, 2022(11).
- . Optica, 8(12), 1588-1595.
- . npj Breast Cancer, 7(1).
- . Mechanisms of Ageing and Development, 192, 111361-111361.
- .
- . Journal of Molecular Medicine, 98(7), 923-930.
- . International Journal of Molecular Sciences, 21(12).
- . Science Advances, 5(10).
- . JCI Insight, 4(17).
- . Proceedings of the National Academy of Sciences, 116(26), 13067-13076.
- . Brain, Behavior, and Immunity, 76, 126-138.
- . Nature Medicine, 24(9), 1418-1429.
- . Journal of the American Heart Association, 7(13).
- . Pulmonary Circulation, 7(4), 768-776.
- . JACC: Basic to Translational Science, 2(4), 398-414.
- . Oncotarget, 7, 75571-75584.
- . Circulation Research, 119, 450-462.
- . Journal of Clinical Investigation, 126(7), 2495-2508.
- . Annals of Neurology, 75(5), 670-683.
- . Journal of Biological Chemistry.
Preprints
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
All publications
Journal articles
- . Atherosclerosis, 407, 120035-120035.
- . Atherosclerosis, 407, 119765-119765.
- . Neurophotonics, 12(S1).
- . Atherosclerosis, 404.
- . Neurophotonics, 12(S1).
- . Cardiovascular Research, 121(5), 748-759.
- . Scientific Reports, 14(1).
- . Journal of the American Heart Association, 13(5).
- . Disease Models & Mechanisms, 16(7).
- . Frontiers in Cellular and Infection Microbiology, 13.
- . Alzheimer's & Dementia, 18(S6).
- . Vascular Biology, 4(1), 11-18.
- . Science Advances, 8(35).
- . Frontiers in Cardiovascular Medicine, 9.
- . eLife, 2022(11).
- . Optica, 8(12), 1588-1595.
- . npj Breast Cancer, 7(1).
- . Journal of Clinical Investigation, 131(11).
- . Mechanisms of Ageing and Development, 192, 111361-111361.
- .
- . Journal of Molecular Medicine, 98(7), 923-930.
- . International Journal of Molecular Sciences, 21(12).
- .
- . Scientific Reports, 10(1).
- . SCIENTIFIC REPORTS, 10(1).
- .
- . Nature Communications, 11(1).
- . Nature Communications, 10(1).
- . Science Advances, 5(10).
- . Open Forum Infectious Diseases, 6(Supplement_2), S207-S207.
- . JCI Insight, 4(17).
- . Proceedings of the National Academy of Sciences, 116(29), 14782-14782.
- . Proceedings of the National Academy of Sciences, 116(26), 13067-13076.
- . Basic Science, A178.2-A178.
- . Basic Science, A172.1-A172.
- . Basic Science, A155.2-A155.
- . Journal of Clinical Endocrinology and Metabolism, 104(4), 1187-1199.
- . Brain, Behavior, and Immunity, 76, 126-138.
- . BMC Neuroscience, 19.
- . Cardiovascular Research, 114(14), 1845-1847.
- . Cardiovascular Research, 114(suppl_2), S2-S2.
- . Nature Medicine, 24(9), 1418-1429.
- . Journal of the American Heart Association, 7(13).
- . European Journal of Preventive Cardiology, 25(9), 948-955.
- . Pulmonary Circulation, 8(1).
- . Cardiovascular Research, 113(13), 1639-1652.
- . Pulmonary Circulation, 7(4), 768-776.
- . JACC: Basic to Translational Science, 2(4), 398-414.
- . Scientific Reports, 7.
- . Oncotarget, 7, 75571-75584.
- . Circulation Research, 119, 450-462.
- . Journal of Clinical Investigation, 126(7), 2495-2508.
- . Annals of Biomedical Engineering, 44(2), 453-465.
- . Circulation, 132(suppl_3).
- . Circulation, 132(suppl_3).
- . Biochemical Society Transactions, 43, 1069-1074.
- . Molecular & Cellular Oncology, 2(3).
- . Cell Death and Differentiation, 22(1), 131-144.
- . EuroIntervention, 10(6), 709-716.
- . Atherosclerosis, 235(2), 613-618.
- . Heart, 100(Suppl 3), A88.2-A89.
- . Heart, 100 Suppl 3, A116-A117.
- . Heart, 100.
- . Annals of Neurology, 75(5), 670-683.
- . PLoS ONE, 9(3).
- . PLoS One, 9(2), e88767.
- . Cardiovasc Res, 102(3), 429-435.
- . PLoS One, 9(2), e88388.
- . Heart, 100 Suppl 1, A2.
- Neutrophil elastase enhances IL-1β secretion from coronary endothelium via an endolysosomal mediated mechanism, without caspase-1 activation. ANGIOGENESIS, 17(4), 941-941.
- . Prog Mol Biol Transl Sci, 124, 1-18.
- . European Heart Journal, 34(22), 1636-1643.
- . Biochim Biophys Acta, 1831(10), 1573-1578.
- . PLoS One, 8(1), e54636.
- The role of vessel wall P2Y12 in early atherogenesis is not blocked by ticagrelor or clopidogrel. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 11, 156-156.
- . J Infect, 66(1), 1-17.
- . Biology (Basel), 1(1), 43-57.
- . Heart, 98(Suppl 3), A6.1-A6.
- . J Exp Med, 209(11), 1919-1935.
- . Journal of the American Heart Association, 1(3).
- . Pulm Circ, 2(1), 21-27.
- . Journal of Innate Immunity, 4(3), 260-272.
- . Heart, 97(20), e7.26-e7.
- . Heart, 97(20), e7-e7.
- . Am J Pathol, 179(4), 1693-1705.
- . Arteriosclerosis Thrombosis and Vascular Biology, 31, 1988-1990.
- . J Leukoc Biol, 90(5), 855-865.
- . Atherosclerosis, 215(2), 348-354.
- . Brain, Behavior, and Immunity, 25(6), 1113-1122.
- Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain, Behavior, and Immunity.
- TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice. Atherosclerosis.
- . PLoS Pathog, 7(1), e1001262.
- . Arterioscler Thromb Vasc Biol, 30(12), 2385-2391.
- . Heart, 96(17), e27-e27.
- . Heart, 96(17), e18-e18.
- . J Biol Chem, 285(30), 23147-23158.
- Sustained P2Y12 Receptor Inhibition is Required to Effectively Inhibit Neointima Formation in a Murine Vascular Injury Model. CIRCULATION, 122(21).
- . TRANSFUS APHER SCI, 42(1), 97-99.
- . Immunology, 128(1), 58-68.
- . Cardiovasc Res, 85, 38-44.
- . Atherosclerosis Supplements, 10(2), e463-e463.
- . Plos One, 4(4), Art No.e5073.
- . Clin Exp Immunol, 156(3), 386-394.
- . Circulation, 119(1), 116-122.
- . Int Immunol, 20(12), 1543-1550.
- . FEBS Lett, 582(6), 886-890.
- . Immunol Lett, 116(2), 178-183.
- . The American Journal of Pathology, 172(1), 256-264.
- . Journal of Thrombosis and Haemostasis, 5.
- . Br J Pharmacol, 151(1), 115-127.
- . Circulation, 116(suppl_16).
- . J Biol Chem, 282(25), 18379-18387.
- Deletion of tumour necrosis factor-related apoptosis-inducing ligand attenuates development of atherosclerosis in ApoE null mice. EUROPEAN HEART JOURNAL, 28, 110-110.
- . Vascular Pharmacology, 45(3), e28-e28.
- . Cytokine, 33(5), 274-280.
- . The American Journal of Pathology, 168(4), 1396-1403.
- . Immunol Lett, 104(1-2), 171-177.
- . Am Heart J, 150(3), 488-499.
- . Cardiovasc Res, 68(3), 493-501.
- . Gene Ther, 12(14), 1154-1157.
- . Journal of Thrombosis and Haemostasis, 3(2), 287-291.
- . Journal of Thrombosis and Haemostasis, 2(11), 2053-2054.
- . The American Journal of Human Genetics, 75(3), 436-447.
- . J Immunol, 173(2), 1202-1208.
- . Heart, 90(6), 591-592.
- . Cardiovascular Pathology, 13(3), 93-93.
- . Cardiovascular Pathology, 13(3), 117-117.
- . Cardiovascular Pathology, 13(3), 95-95.
- . Cardiovascular Pathology, 13(3), 116-117.
- . Cardiovascular Pathology, 13(3), 127-127.
- . Clinical Science, 106(s50), 2P-2P.
- . Lab Invest, 83(10), 1497-1508.
- . Circ Res, 92(12), 1285-1287.
- . Ultrasound Med Biol, 29(10), 1453-1461.
- . Biochemical Society Transactions, 30(5), A130-A130.
- . Clin Sci (Lond), 103(3), 303-310.
- . Cold Spring Harbor Symposia on Quantitative Biology, 67, 143-153.
- . Arterioscler Thromb Vasc Biol, 22(6), 927-933.
- Differential regulation of endothelial function and systemic inflammation by gene variation at the IL-1 locus during acute coronary syndromes. CIRCULATION, 104(17), 390-391.
- Polymorphism at the IL-1 locus determines the endothelial but not the systemic response in acute coronary syndromes. EUR HEART J, 22, 373-373.
- . Heart, 86(3), 336-340.
- . Cardiovasc Res, 50(1), 125-136.
- . Circulation, 103(8), 1135-1141.
- . Arterioscler Thromb Vasc Biol, 21(11), 1727-1732.
- . Gene Ther, 7(23), 2023-2027.
- A cell kinetic analysis of human umbilical vein endothelial cells. MECH AGEING DEV, 120(1-3), 23-32.
- Possible different involvement of interleukin-1 receptor antagonist gene polymorphism in coronary single vessel disease and myocardial infarction - Response. CIRCULATION, 101(18), E193-E193.
- Antisense oligonucleotide to c-myb induces apoptosis in vascular smooth muscle cells in vitro and in vivo. Heart, 83(SUPPL. 1), P17.
- Mammalian suppressor of sgv-1 (MSS1), a putative transcription factor and differentiation related gene, is upregulated in explant derived compared with enzyme dispersed human aortic vascular smooth muscle cells in vitro. J AM COLL CARDIOL, 35(2), 49A-49A.
- VEGF promoter polymorphisms and the risk of ischaemic heart disease. J AM COLL CARDIOL, 35(2), 306A-306A.
- . Arteriosclerosis, Thrombosis, and Vascular Biology, 20(11), 2394-2400.
- . Cardiovasc Res, 44(2), 436-448.
- . Cardiovascular Research, 44(1), 156-165.
- . Circulation, 99(20), 2617-2620.
- Interleukin-1 receptor antagonist (IL-1RA) in human diseased arteries: Association of allele 2 of IL-1RN (+2016) human gene polymorphism with reduced expression in endothelial cells. Heart, 81(SUPPL. 1), P25.
- . Circulation, 99(7), 861-866.
- . Methods Mol Med, 30, 39-46.
- . Clinical Science, 95(6), 659-659.
- Transforming growth factor-beta gene polymorphisms and coronary artery disease. CLIN SCI, 95(6), 659-667.
- . Perfusion, 13(6), 409-417.
- . Heart, 80(5), 509-516.
- . Circulation, 98(16), 1657-1665.
- 1MHz ultrasound enhances transfection of porcine aortic endothelial cells in vitro and oligonucleotide uptake in an organ culture model.. AM J CARDIOL, 82(7A), 29S-29S.
- Aorto-ostial stent: Procedural, angiographic and histological evaluation in porcine coronary arteries.. AM J CARDIOL, 82(7A), 68S-68S.
- . Clinical Science, 95(3), 311-315.
- Methylenetetrahydrofolate reductase polymorphism (C-677T) and coronary artery disease. CLIN SCI, 95(3), 311-315.
- Interleukin-1 (IL-1) gene polymorphisms: Risk of coronary arterial disease. Heart, 79(SUPPL. 1), P46.
- Apoptosis and cell proliferation following porcine angioplasty. J AM COLL CARDIOL, 31(2), 22A-22A.
- Nigh frequency ultrasound enhances transfection of porcine vascular smooth muscle cells in vitro. J AM COLL CARDIOL, 31(2), 25A-25A.
- . J Mol Cell Cardiol, 30(2), 215-223.
- Modulation of Bcl-2 and the related proteins Bak and Bax during in vitro ageing of HUVEC. Heart, 77(SUPPL. 1), P16.
- In-stent restenosis: More metal and more symmetry required?. Heart, 77(SUPPL. 1), P46.
- Z-VAD but not Z-DEVD inhibits serum withdrawal induced apoptosis of HUVEC in vitro. Heart, 77(SUPPL. 1), P17.
- The BioDivYsio(R) stent: Morphometric superiority to the Palmaz-Schatz stent in the porcine coronary model. AMERICAN JOURNAL OF CARDIOLOGY, 80, TCT95-TCT95.
- . Circ Res, 80(4), 520-531.
- Neutrophils are a source of interleukin-6 in human cardiopulmonary bypass surgery. HEART, 75(5), 100-100.
- c-fms proto-oncogene expression is increased in endothelial and smooth muscle cells following vascular grafting. HEART, 75(5), 161-161.
- Early response gene expression and vascular cell proliferation in human saphenous vein prepared for coronary bypass grafting. HEART, 75(5), 279-279.
- Apoptosis of human umbilical vein endothelial cells (HUVEC) - Role of interleukin-1 beta converting enzyme (ICE) and associated proteases. HEART, 75(5), 11-11.
- Restenosis after balloon angioplasty: Intimal hyperplasia or vessel remodelling?. HEART, 75(5), 88-88.
- . Arterioscler Thromb Vasc Biol, 16(8), 1000-1006.
- UP-REGULATION OF THE EARLY RESPONSE GENES C-FOS, C-JUN AND C-MYC IN SURGICALLY PREPARED HUMAN SAPHENOUS-VEIN. CIRCULATION, 92(8), 3080-3080.
- INTRA-CORONARY DRUG-DELIVERY VIA POROUS BALLOON - LOCAL OR REGIONAL. CIRCULATION, 92(8), 3220-3220.
- . Cardiovasc Surg, 3(2), 171-174.
- . Journal of the American College of Cardiology, 25(2), 376A-377A.
- . Cardiovasc Res, 28(8), 1170-1175.
- DETECTION OF IL-1 IN HUMAN ATHEROSCLEROSIS. J CELL BIOCHEM, 285-285.
- INTERLEUKIN-10 IN HUMAN ARTERIES AND VEINS. J CELL BIOCHEM, 284-284.
- Release of platelet-derived growth factor activity from pig venous arterial grafts.. J Thorac Cardiovasc Surg, 108(3), 540-548.
- . International Journal of Angiology, 2(03), 105-111.
- . Nucleic Acids Res, 21(12), 2944.
- . Biochimica et Biophysica Acta (BBA) - Biomembranes, 1147(2), 251-261.
- . Ann Thorac Surg, 55(6), 1522-1528.
- . The Journal of Pathology, 166(4), 417-420.
- . Cardiovasc Res, 26(12), 1189-1194.
- SERUM-FREE ORGAN-CULTURE OF VASCULAR TISSUES. IN VITRO CELL DEV-AN, 28A(11-12), 693-694.
- . Colloids and Surfaces, 62(1-2), 177-184.
- ANOTHER CAUTIONARY NOTE ON THE USE OF PCNA. J PATHOL, 166(4), 418-418.
- HEPARIN AND NEOINTIMAL THICKENING IN AN ORGAN-CULTURE OF HUMAN SAPHENOUS-VEIN. ATHEROSCLEROSIS, 93(1-2), 155-156.
- . Biochimica et Biophysica Acta (BBA) - Biomembranes, 1062(2), 117-122.
- . Biochimica et Biophysica Acta (BBA) - Biomembranes, 987(2), 212-216.
- . Biochemical Society Transactions, 17(3), 558-559.
- . Biochimica et Biophysica Acta (BBA) - Biomembranes, 978(1), 17-24.
- . Journal of Cardiovascular Pharmacology, 78(5), e656-e661.
- Interleukin-1β promotes an atheroprotective distribution of smooth muscle cells and macrophages in late stage murine atherosclerotic lesions. Nature Medicine.
- . Journal of Biological Chemistry.
- . PLoS ONE, 9(5), e97392-e97392.
- . International Journal of Angiology, 2(03), 105-111.
Book chapters
- (pp. 331-340).
Conference proceedings
- Modulating The Role And Function Of Macrophages In Human Symptomatic Carotid Stenosis: Potential Mechanisms For Stabilisation Of Atherosclerotic Carotid Plaques. INTERNATIONAL JOURNAL OF STROKE, Vol. 19(3_SUPPL) (pp 39-39)
- . 13.01 - Pulmonary hypertension (pp 105-105)
- . A14. THIS IS GETTING COMPLICATED: EPIGENETICS, -OMICS, AND CELL SIGNALING IN PULMONARY HYPERTENSION (pp A1011-A1011)
- . Basic science (pp A172.2-A173)
- . Basic science (pp A156.1-A156)
- The effect of systemic atherosclerosis on the neurovascular unit. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, Vol. 47 (pp 21-21)
- . A107. BYSTANDERS NO MORE: INFLAMMATION, IMMUNITY AND THROMBOSIS IN PULMONARY VASCULAR AND LUNG DISEASE (pp A2679-A2679)
- Myeloid TRIB1 Controls Metabolic Tissue Resident Macrophage Phenotype Associated with Immuno-Metabolic Diseases. CARDIOVASCULAR DRUGS AND THERAPY, Vol. 33(2) (pp 271-271)
- The effect of systemic atherosclerosis in the neurovascular unit. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, Vol. 45 (pp 31-31)
- . Cardiovascular Research, Vol. 114(suppl_2) (pp S5-S6)
- . Cardiovascular Research, Vol. 114(suppl_2) (pp S4-S4)
- . Heart, Vol. 104(Suppl 6) (pp A102-A103). Manchester, UK, 4 June 2018 - 4 June 2018.
- . Basic Science (pp A78.1-A78)
- . Basic Science (pp A93.1-A93)
- . Basic Science (pp A90.1-A90)
- . Atherosclerosis Supplements, Vol. 32 (pp 11-11)
- Acute hypoglycaemia results in increased activation of responses to an inflammatory challenge induced 48 hours later in human subjects. DIABETOLOGIA, Vol. 61 (pp S446-S446)
- CONSEQUENCES OF TRIB3 DEFICIENCY ON EXPERIMENTAL ATHEROSCLEROSIS AND MACROPHAGE PHENOTYPE. CARDIOVASCULAR RESEARCH, Vol. 114 (pp S2-S2)
- Expression of SMURF1 is Increased in Patients With Pulmonary Arterial Hypertension and SiRNA Inhibition of SMURF1 Reduces Pulmonary Artery Smooth Muscle Cell Proliferation. CIRCULATION, Vol. 138
- . Heart, Vol. 103(Suppl 5) (pp A113.2-A113)
- . Heart, Vol. 103(Suppl 5) (pp A139.2-A140)
- Effect of Hypoglycemia on Platelet Reactivity and Platelet-Leukocyte Kinetics. DIABETES, Vol. 66 (pp A41-A41)
- Hypoglycaemia increases platelet reactivity and promotes formation of proatherogenic platelet-leucocyte aggregates. DIABETOLOGIA, Vol. 60 (pp S532-S532)
- Development of a Novel Human Anti-OPG Antibody That Attenuates Experimental Pulmonary Arterial Hypertension. CIRCULATION, Vol. 136
- . Heart View (pp A116.2-A117)
- . HEART, Vol. 102 (pp A147-A147)
- . Heart, Vol. 102(Suppl 6) (pp A123.2-A124), 6 June 2016 - 8 June 2016.
- . Heart, Vol. 102(Suppl 6) (pp A140.1-A140), 6 June 2016 - 8 June 2016.
- . Heart, Vol. 102(Suppl 6) (pp A114.2-A114), 6 June 2016 - 8 August 2016.
- Hypoglycemia Increases Circulating Proatherogenic Intermediate Monocytes in Healthy Volunteers. DIABETES, Vol. 65 (pp A104-A104)
- . Thorax, Vol. 70(Suppl 3) (pp A5.3-A6)
- . Thorax, Vol. 70(Suppl 3) (pp A3.1-A3)
- . Atherosclerosis, Vol. 241(1) (pp e34-e34)
- . Basic Science (pp A107.2-A107)
- . Heart, Vol. 101(Suppl 4) (pp A118.2-A119)
- . Heart, Vol. 101(Suppl 4) (pp A104.2-A105)
- . Basic Science (pp A117.2-A118)
- . Atherosclerosis, Vol. 237(2) (pp e2-e2)
- . Thorax, Vol. 69(Suppl 2) (pp A2-A3)
- . Diseases, Vol. 2(3) (pp 260-273)
- . Heart, Vol. 100(Suppl 3) (pp A104.2-A105)
- Bone Marrow Derived Osteoprotegerin Drives Experimental Pulmonary Arterial Hypertension In The Murine Sugen/hypoxia Model. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol. 189
- . Heart, Vol. 99(suppl 2) (pp A7-A7)
- . Heart, Vol. 99(suppl 2) (pp A99.2-A99)
- . The Lancet, Vol. 381, Supplement 1 (pp S47 --S47 -)
- . HEART, Vol. 98 (pp A1-A1)
- . B26. PULMONARY VASCULAR SIGNALING IN PULMONARY HYPERTENSION (pp A2609-A2609)
- . D97. PULMONARY HYPERTENSION: NEW INSIGHTS INTO CAUSES AND TREATMENTS? (pp A6515-A6515)
- . THORAX, Vol. 66 (pp A3-A3)
- . Thorax, Vol. 66(Suppl 4) (pp A34-A34)
- . Heart, Vol. 97(20) (pp e7.12-e7)
- . HEART, Vol. 97(20) (pp 10-10)
- . B61. PULMONARY HYPERTENSION: EXPERIMENTAL MODELS I (pp A3407-A3407)
- . THORAX, Vol. 65 (pp A68-A68)
- . A96. INFLAMMATION AND BONE MARROW DERIVED CELLS IN PULMONARY ARTERIAL HYPERTENSION (pp A2283-A2283)
- . THORAX, Vol. 64 (pp A9-A10)
- . THORAX, Vol. 64 (pp A58-A59)
- . THORAX, Vol. 64 (pp A8-A8)
- . THORAX, Vol. 64 (pp A9-A9)
- . THORAX, Vol. 64 (pp A9-A9)
- . HEART, Vol. 95(22)
- Fat Fed ApoE/IL-1R1 Double Deficient Mice Are Protected From Atherosclerosis but Develop Severe Pulmonary Hypertension. CIRCULATION, Vol. 120(18) (pp S751-S751)
- OPG:TRAIL Ratio as a Potential Biomarker for Pulmonary Arterial Hypertension. CIRCULATION, Vol. 120(18) (pp S806-S806)
- IL-1 MODULATES BLOOD PRESSURE IN MICE AND MAN. ATHEROSCLEROSIS SUPPLEMENTS, Vol. 10(2)
- IL-1 MODULATES BLOOD PRESSURE IN MICE AND MAN. ATHEROSCLEROSIS SUPPLEMENTS, Vol. 10(2). Boston, MA, 14 June 2009 - 18 June 2009.
- A NOVEL MURINE MODEL OF STENTING. HEART, Vol. 95 (pp A37-A38)
- THE OSTEOPROTEGERIN-TNF-RELATED APOPTOSIS-INDUCING LIGAND AXIS IN PULMONARY ARTERIAL HYPERTENSION. THORAX, Vol. 63 (pp A28-A28)
- Low-density lipoprotein controls IL-8 production in monocytes via tribbles-2. HEART, Vol. 94 (pp A44-A44)
- The platelet P2Y12 receptor influences the vessel wall response to arterial injury and thrombosis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 51(10) (pp A291-A291)
- Leucodepletion filters do not eliminate circulating endothelial cells (CECs) in human whole blood donations. BRITISH JOURNAL OF HAEMATOLOGY, Vol. 141 (pp 113-113)
- A potential role for TRAIL in the pathogenesis of pulmonary arterial hypertension. CIRCULATION, Vol. 116(16) (pp 59-59)
- . Atherosclerosis, Vol. 193(2) (pp S5-S5)
- A potential role for osteoprotegerin in idiopathic pulmonary arterial hypertension. HEART, Vol. 93 (pp A23-A24)
- Bidirectional signalling between monocytes and endothelial cells regulate responses to TLR4 agonists in coculture models of vascular inflammation. JOURNAL OF LEUKOCYTE BIOLOGY (pp 51-51)
- . Vascular Pharmacology, Vol. 45(3) (pp e106-e106)
- Interaction between tumour necrosis factor-related apoptosis inducing ligand & osteoprotegerin in acute coronary syndromes. EUROPEAN HEART JOURNAL, Vol. 27 (pp 229-229)
- The effect of Interleukin-1 receptor antagonist on restenosis - continued suppression of neointima at 90 days. EUROPEAN HEART JOURNAL, Vol. 27 (pp 230-231)
- The P2Y12 receptor regulates the vessel wall response to arterial injury and thrombosis. EUROPEAN HEART JOURNAL, Vol. 27 (pp 753-753)
- Soluble tumour necrosis factor-related apoptosis inducing ligand is low early in the presentation of acute coronary syndromes and is inversely correlated with C-reactive protein and troponin T. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, Vol. 47(4) (pp 194A-194A)
- The P2Y12 receptor regulates the vessel wall response to arterial injury and thrombosis. HEART, Vol. 92 (pp A111-A111)
- Tribbles-1, a mitogen activated protein kinase (MAPK) scaffold regulates inflammation in vascular smooth muscle cells (VSMC) and atherosclerosis. HEART, Vol. 91 (pp A15-A15)
- Investigation of P2X7 dependent mechanisms of interleukin-1 beta (IL-1 beta) release from human endothelial cells. HEART, Vol. 91 (pp A13-A13)
- A new murine model of arterial stenting. HEART, Vol. 91 (pp A51-A51)
- Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model. CIRCULATION, Vol. 110(17) (pp 161-161)
- Interleukin-1 receptor antagonist (IL-1ra) modulates the porcine coronary arterial response to stenting. ATHEROSCLEROSIS, Vol. 174(1) (pp S4-S4)
- Interleukin 1 receptor antagonist (IL 1ra) modulates the response to oversized balloon angioplasty and stenting in a porcine coronary artery model. HEART, Vol. 90 (pp A1-A2)
- Interleukin-1 receptor antagonist (IL-1ra) modulates the porcine coronary arterial response to oversized balloon angioplasty and stenting. CIRCULATION, Vol. 108(17) (pp 195-195)
- Adjunctive ultrasound exposure enhances gene delivery to vascular smooth muscle cells in vitro and to ex vivo and in vivo porcine saphenous vein grafts. AMERICAN JOURNAL OF CARDIOLOGY, Vol. 92(6A) (pp 100L-100L)
- IL-1 RN (VNTR) gene polymorphism predicts clinical events up to 1 year after a non-ST-elevation acute coronary syndrome: An association independent of troponin T and C-reactive protein. EUROPEAN HEART JOURNAL, Vol. 24 (pp 70-70)
- IL-1RN (VNTR) gene polymorphism predicts a proinflammatory endothelial cell phenotype in HUVEC-Implications for atherogenesis and plaque rupture. EUROPEAN HEART JOURNAL, Vol. 23 (pp 594-594)
- Modulation of MSS1, a component of the 26S proteasome, in vascular smooth muscle cells in vitro and following experimental PTCA. EUR HEART J, Vol. 22 (pp 3-3)
- Ultrasound-enhanced reporter gene expression following naked DNA transfection is markedly enhanced by the presence of microbubble contrast agents.. AM J CARDIOL, Vol. 84(6A) (pp 64P-65P)
- IL-1 beta synthesis and neovascularisation following porcine coronary arterial injury. J VASC RES, Vol. 35(5) (pp 389-389)
- . Journal of the American College of Cardiology, Vol. 31 (pp 25-25)
- Is local drug delivery truly a low efficiency procedure?. AMERICAN JOURNAL OF CARDIOLOGY, Vol. 80 (pp TC240-TC240)
- . Biochemical Society Transactions, Vol. 18(5) (pp 876-877)
- Neutrophil elastase enhances IL-1 beta secretion from coronary endothelium via an endolysosomal mediated mechanism, without caspase-1 activation. ANGIOGENESIS, Vol. 17(4) (pp 941-941). California, USA, 18 October 2014 - 23 October 2014.
Preprints
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Research Square Platform LLC.
- , arXiv.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- .
- Research group
-
- Dr Osman Shabir
- Dr Aya Elwazir (now honorary Fellow)
- Mr Kieran Bowden
- Miss Pooja Atul Patel
- Dr Janet Chamberlain
- Mr David Reid
- Ms Priscila Hirschfield
- Mr Oliver Heaney (with the Shaw group)
- Mr Rahul Sidhu (with the Howarth/Berwick group)
- Mr Tom Chittenden (with the Shabir/Berwick group)
- Miss Harriet Brooke (with the Wharton and Simpson group)
- Teaching interests
-
I am a Senior Fellow of the Higher Education Academy. I teach on phase 2a (Cardiovascular Medicine) for the UG MBChB course. I also teach on CDL301 ‘Modern approaches to Cardio-Respiratory Medicine’ led by Dr Janet Chamberlain Dr Lisa Parker and Professor Nigel Wheeldon.
- Professional activities and memberships
-
- Secretary of the (September 2018 - 2023)
- European Atherosclerosis Society Distinguished Awards and Prizes Committee Chairperson (2025 - present)
- Fellowships Committee, British Heart Foundation (July 2020 – 2024)
- Academy of Medical Sciences, Springboard Awards Committee (November 2022 - present)